{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:52:07Z","timestamp":1788274327117,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.gore.2025.101754","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T18:54:15Z","timestamp":1746298455000},"page":"101754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Trastuzumab monotherapy as maintenance treatment for metastatic HER2+\u00a0vulvar Paget disease: systematic review and case report"],"prefix":"10.1016","volume":"59","author":[{"given":"Dalila","family":"Incognito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giosu\u00e8 Giordano","family":"Incognito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando Antonio","family":"Gulino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Canzonieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gelsomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Picone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2025.101754_b0065","article-title":"Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature","volume":"2015","author":"Barth","year":"2015","journal-title":"Case Rep. Oncol. Med."},{"issue":"11","key":"10.1016\/j.gore.2025.101754_b0070","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/ijgc-2020-001771","article-title":"Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva","volume":"30","author":"Bartoletti","year":"2020","journal-title":"International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society"},{"key":"10.1016\/j.gore.2025.101754_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.gore.2020.100602","article-title":"Treatment of invasive Paget's disease of the vulva in pregnancy: A case report","volume":"33","author":"Bruce","year":"2020","journal-title":"Gynecologic Oncology Reports"},{"issue":"4","key":"10.1016\/j.gore.2025.101754_b0095","article-title":"Long-Term Complete Response and Survival in Metastatic Extramammary Paget's Disease Treated with Trastuzumab Plus Paclitaxel: A Case Report","volume":"16","author":"Chilelli","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.gore.2025.101754_b0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fonc.2018.00038","article-title":"Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach","volume":"8","author":"Fukuda","year":"2018","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2025.101754_b0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000333002","article-title":"A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy","volume":"3","author":"Hanawa","year":"2011","journal-title":"Case Rep. Dermatol."},{"issue":"4","key":"10.1016\/j.gore.2025.101754_b0040","first-page":"2969","article-title":"Extramammary Paget's Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments","volume":"28","author":"Ishizuki","year":"2021","journal-title":"Curr. Oncol. (Toronto Ont.)"},{"issue":"1","key":"10.1016\/j.gore.2025.101754_b0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.annder.2020.08.048","article-title":"Complete but transient clinical remission of vulvar Paget's disease with paclitaxel and trastuzumab","volume":"148","author":"Isnard","year":"2021","journal-title":"Ann. Dermatol. Venereol."},{"issue":"3","key":"10.1016\/j.gore.2025.101754_b0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2007.12.014","article-title":"HER-2\/neu targeting for recurrent vulvar Paget's disease A case report and literature review","volume":"111","author":"Karam","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.gore.2025.101754_b0045","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/jamaoncol.2021.7148","article-title":"Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease","volume":"8","author":"Kibbi","year":"2022","journal-title":"JAMA Oncology"},{"issue":"1","key":"10.1016\/j.gore.2025.101754_b0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/1346-8138.15096","article-title":"Case of metastatic extramammary Paget's disease treated with trastuzumab-biosimilar monotherapy after S-1 and docetaxel combination chemotherapy","volume":"47","author":"Kimura","year":"2020","journal-title":"J. Dermatol."},{"key":"10.1016\/j.gore.2025.101754_b0055","doi-asserted-by":"crossref","first-page":"210]","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.gore.2025.101754_b0050","doi-asserted-by":"crossref","unstructured":"Page, M.J., McKenzie, J.E., Bossuyt, P.M., Boutron, I., Hoffmann, T.C., Mulrow C.D., Shamseer, L., Tetzlaff, J.M., Akl, E.A., Brennan, S.E., Chou, R., Glanville, J., Grimshaw, J.M., Hrobjartsson, A., Lalu, M.M., Li, T., Loder, E.W., Mayo-Wilson, E., McDonald, S., McGuinness, L.A., Stewart, L.A., Thomas, J., Tricco, A.C., Welch, V.A., Whiting, P., Moher, D., 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed.) 2023, 372, n71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"issue":"6","key":"10.1016\/j.gore.2025.101754_b0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jcp.2010.077446","article-title":"HER-2\/NEU overexpression in vulvar Paget disease: the Yale experience","volume":"63","author":"Richter","year":"2010","journal-title":"J. Clin. Pathol."},{"issue":"11","key":"10.1016\/j.gore.2025.101754_b0010","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/1346-8138.15515","article-title":"Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget's disease: Four cases and a review","volume":"47","author":"Sekiguchi","year":"2020","journal-title":"J. Dermatol."},{"issue":"8","key":"10.1016\/j.gore.2025.101754_b0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1346-8138.2009.00676.x","article-title":"Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy","volume":"36","author":"Takahagi","year":"2009","journal-title":"J. Dermatol."},{"key":"10.1016\/j.gore.2025.101754_b0085","article-title":"Dramatic Clinical Response of Relapsed Metastatic Extramammary Paget's Disease to Trastuzumab Monotherapy","volume":"2012","author":"Wakabayashi","year":"2012","journal-title":"Case Rep. Dermatol. Med."},{"issue":"3","key":"10.1016\/j.gore.2025.101754_b0030","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10637-016-0329-8","article-title":"Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease","volume":"34","author":"Watanabe","year":"2016","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.gore.2025.101754_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.925551","article-title":"Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin","volume":"12","author":"Zattarin","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:05:40Z","timestamp":1750201540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578925000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":19,"alternative-id":["S2352578925000797"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101754","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trastuzumab monotherapy as maintenance treatment for metastatic HER2+\u00a0vulvar Paget disease: systematic review and case report","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101754"}}